Chemotherapy Optimization using Moving Horizon Estimation based Nonlinear Model Predictive Control
Authors:
- Bence CzakóBCBence Czakó
- Máté SiketMSMáté Siket
- Dániel András DrexlerDDDániel András Drexler
- Levente KovácsLKLevente Kovács
- 1 January 2021
- journal article
- research article
- Published by Elsevier in IFAC-PapersOnLine
- Vol. 54 (15) , 215-220
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Sensitivity and identifiability analysis of a third-order tumor growth model2020
- Impulsive Control of Tumor Growth via Nonlinear Model Predictive Control Using Direct Multiple Shooting2020
- Experimental data-driven tumor modeling for chemotherapyIFAC-PapersOnLine, 2020
- Qualitative analysis of a closed-loop model of tumor growth control2018
- Pegylated liposomal formulation of doxorubicin overcomes drug resistance in a genetically engineered mouse model of breast cancerJournal of Controlled Release, 2017
- Optimization of an in vitro chemotherapy to avoid resistant tumoursJournal of Theoretical Biology, 2017
- Tumor Volume Estimation and Quasi-Continuous Administration for Most Effective Bevacizumab TherapyPLOS ONE, 2015
- Optimal dosing of cancer chemotherapy using model predictive control and moving horizon state/parameter estimationComputer Methods and Programs in Biomedicine, 2012
- A survey of optimization models on cancer chemotherapy treatment planningAnnals of Operations Research, 2011